TABLE 2.
Association Between Patient Reimbursement Timing and Adherence to Prescribed Medications, as Measured by PDC
| Adjusted Mean Difference in PDC (%) n = 1,782 | 95% CI | |
| Deferred vs. immediate patient reimbursement | 0.0 | -3.0 to 3.0 |
| Age (years) | ||
| 18-34 | Reference | |
| 35-49 | 3.0 | 0.0 to 6.0 |
| 50-64 | 8.0 | 4.0 to 12.0 |
| BMI at reMed recruitment | ||
| Underweight | 1.0 | -9.0 to 10.0 |
| Normal | Reference | |
| Overweight | 3.0 | 0.0 to 6.0 |
| Obese | 3.0 | 0.0 to 7.0 |
| Medication under study at cohort entry | ||
| Antidepressants | 27.0 | 23.0 to 31.0 |
| Antihypertensive drugs | 31.0 | 25.0 to 37.0 |
| Antipsychotics | 11.0 | 4.0 to 17.0 |
| Treatment for asthma and COPDa | -11.0 | -15.0 to -7.0 |
| Antithrombotics | 37.0 | 25.0 to 49.0 |
| Proton pump inhibitors | Reference | |
| Oral antidiabetics | 33.0 | 25.0 to 42.0 |
| Statins | 48.0 | 42.0 to 53.0 |
| Thyroid hormones | 55.0 | 47.0 to 62.0 |
aInhaled corticosteroids (ICS), long-acting beta agonists (LABA), ICS + LABA, anticholinergics.
BMI = body mass index; CI = confidence interval; COPD = chronic obstructive pulmonary disease; PDC = proportion of days covered.